COVID-19 patients respond positively to Gilead Sciences experimental drug

Shares of Gilead Sciences Inc’s shares jumped by 16% following news reports that its experimental drug remdesivir is proving to be effective in U.S. trials of patients who have been severely afflicted by the COVID-19 disease caused by the coronavirus. According to a report from medical news website STAT, a University of Chicago hospital participating…

Long term short-seller Citron Research now bets on Tesla

Although Tesla’s critics have focused on Elon Musk’s behavior, the numbers coming out of Tesla are pretty compelling. In an interesting turn of events, long-time Tesla short seller and critic Citron Research, in its research note stated it is betting that the electric automaker’s stock will rise. With the news reaching the market, Tesla Inc’s…